Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-25 @ 8:24 PM
Study NCT ID:
NCT00256269
Status:
TERMINATED
Last Update Posted:
2018-01-26
First Post:
2005-11-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
Sponsor:
University of California, Irvine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
ACTUAL
Primary Completion Date:
2007-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-17
First Submit QC Date:
None
Study First Post Date:
2005-11-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-24
Last Update Post Date:
2018-01-26
Last Update Post Date Type:
ACTUAL